R3: RNA Readiness + Response is a $60M program, jointly funded with the Coalition for Epidemic Preparedness Innovations (“CEPI”) focused on the development of biofoundries to catalyze the innovation of diverse biologics and to provide economically sustainable, global surge capacity during a pandemic. Such a distributed global network of ‘living’ RNA-based, multi-product biofoundries would support a 1,000 to 10,000-fold increase in the number of innovators developing treatments for cancer, metabolic disorders, cardiovascular conditions, autoimmune diseases, and more. As well, it would provide the capacity to produce billions of doses of RNA-based vaccines in a month, equitably, across the world. This page is where those researchers share and interact about their work. Follow R3 to meet their performers, see their progress, publications, and announcements. https://lnkd.in/dP9qURPs
R3 - RNA Readiness and Response
研究服务
What if a global network of biofoundries could produce billions of vaccine doses in one month?
关于我们
- 网站
-
https://wellcomeleap.org/r3/
R3 - RNA Readiness and Response的外部链接
- 所属行业
- 研究服务